William Blair Highlights Three Energy Stocks for 'Outperform' Potential
The Crystal Ball Gazer: William Blair's Bold Vision for Palantir's Future
The Whisper of Confidence: Why William Blair Just Gave ZVRA a Nod
Krystal Biotech's Ascendant Star: Why William Blair Is Eyeing a Future of Sky-High Earnings
FDA Pumps the Brakes: Denali Therapeutics' Hunter Syndrome Drug Faces Extended Review